What does a negative endomysial antibody (EMA) and a positive gliadin antibody indicate, and how should I evaluate for celiac disease?

Evaluation of Negative Endomysial Antibody with Positive Gliadin Antibody

A positive gliadin antibody with negative endomysial antibody (EMA) is insufficient to diagnose celiac disease and requires further comprehensive serologic testing including tissue transglutaminase (tTG) IgA and total IgA level, followed by duodenal biopsy if indicated. 1

Understanding the Serologic Pattern

Gliadin antibodies are not recommended for celiac disease screening because they lack the specificity of tTG and EMA tests. 1 This antibody pattern (EMA-negative, gliadin-positive) has several possible interpretations:

• Most likely scenario: This represents a false-positive gliadin result, as antigliadin antibodies have poor specificity and are commonly elevated in non-celiac conditions 1
• Less common: This could represent early or mild celiac disease that EMA testing failed to detect, though this is uncommon 2, 3, 4
• IgA deficiency: Must be ruled out, as it causes falsely negative IgA-based tests (EMA, tTG) 5, 1

Recommended Diagnostic Approach

Step 1: Complete the Serologic Panel

Immediately measure the following while the patient remains on a gluten-containing diet: 5

• Total serum IgA level to exclude selective IgA deficiency 5, 1
• Tissue transglutaminase IgA (tTG-IgA) - the most sensitive and specific test 1
• Deamidated gliadin peptide (DGP) IgA for additional sensitivity 5
• If IgA deficient: measure IgG-based tests (tTG-IgG, DGP-IgG, EMA-IgG) 5

Step 2: Interpret Results Based on tTG Findings

If tTG-IgA is positive:

• Refer to gastroenterology for duodenal biopsy to confirm diagnosis 1
• The negative EMA in this context likely reflects EMA's lower sensitivity compared to tTG 1, 2, 3

If tTG-IgA is negative:

• The positive gliadin antibody is likely a false positive 1
• However, if clinical suspicion remains high (symptoms of malabsorption, weight loss, chronic diarrhea, family history), proceed to duodenal biopsy regardless 5
• EMA-negative celiac disease occurs in 15-25% of biopsy-proven cases, particularly with partial villous atrophy 2, 3, 4

Step 3: Consider HLA-DQ2/DQ8 Testing

HLA testing should be performed if: 5

• All serology remains negative but clinical suspicion is high
• Patient has already reduced gluten intake before testing
• Negative HLA-DQ2/DQ8 effectively rules out celiac disease in seronegative patients 5
• Positive HLA supports proceeding to biopsy but does not confirm diagnosis 5

Step 4: Duodenal Biopsy Decision

Proceed with upper endoscopy and duodenal biopsies if: 5, 6

• tTG-IgA or DGP-IgA is positive
• Strong clinical suspicion persists despite negative serology (unexplained iron deficiency, osteoporosis, chronic diarrhea, weight loss) 5
• Patient has HLA-DQ2/DQ8 positivity with symptoms 5

Obtain at least 4-6 duodenal biopsies including bulb and distal duodenum, reviewed by an experienced gastrointestinal pathologist 5

Critical Pitfalls to Avoid

Do not start a gluten-free diet before completing the diagnostic workup, as this reduces sensitivity of both serology and histology. 6 If the patient has already reduced gluten, they must consume at least three slices of wheat bread daily for 1-3 months before repeat testing 6

Do not rely on gliadin antibodies alone - they have been superseded by more specific tests and should not guide clinical decisions independently 1

Do not assume negative EMA rules out celiac disease - studies show 15-25% of biopsy-proven celiac patients are EMA-negative, especially those with partial villous atrophy rather than total villous atrophy 2, 3, 4

Verify the patient's diet at time of testing - inadequate gluten consumption (less than 3-10 grams daily) can cause false-negative results 5

Review medications carefully - angiotensin II receptor blockers like olmesartan can cause villous atrophy mimicking celiac disease 5

Special Considerations

In patients with discordant serology (one positive, others negative), the probability of celiac disease increases when multiple different antibody tests are positive rather than just one 7 The combination of negative tTG and negative EMA with isolated positive gliadin antibody has very low positive predictive value for celiac disease 7, 8

If duodenal biopsy shows villous atrophy but serology remains negative, consider seronegative celiac disease and initiate a trial of gluten-free diet with repeat biopsy in 1-3 years to document histologic improvement, which confirms the diagnosis 5